Join to View Full Profile
55 Fruit St149 7202Boston, MA 02114
Phone+1 617-726-7805
Fax+1 617-724-6919
Dr. Haber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts Institute of TechnologyPost-Doctoral Fellowship, 1987 - 1991
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1990
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986- Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1983 - 1984
Stanford University School of MedicineClass of 1983
Certifications & Licensure
MA State Medical License 1985 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member Fellow of the AACR Academy, 2019
- Elected Member National Academy of Sciences, 2018
- Investigator Howard Hughes Medical Institute
Publications & Presentations
PubMed
- ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.Parasvi S Patel, Jacob P Matson, Xiaojuan Ran, Marcello Stanzione, Ajinkya S Kawale
The Journal of Clinical Investigation. 2026-01-22 - 2 citationsThe E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.Joanna A Vuille, Cem Tanriover, Ezgi Antmen, Douglas S Micalizzi, Richard Y Ebright
Proceedings of the National Academy of Sciences of the United States of America. 2025-08-12 - 18 citationsCirculating tumor cells: Blood-based detection, molecular biology, and clinical applications.Charles S Dai, Avanish Mishra, Jon Edd, Mehmet Toner, Shyamala Maheswaran
Cancer Cell. 2025-08-11
Journal Articles
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerDavid T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research
Press Mentions
SCLC: Small Study Tests Efficacy of CTCs in Predicting Response to TarlatamabJanuary 15th, 2026- Mass General Brigham Announces 2025 Recipients of Krantz Awards for Cancer ResearchDecember 19th, 2025
- Isolation of Circulating Tumor Cells with TellDx Platform Reveals Potential Mechanism of Resistance to Immune Checkpoint Blockade in MelanomaMarch 16th, 2023
Grant Support
- Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor CellsMASSACHUSETTS GENERAL HOSPITAL2008–2028
- Training Program in Cancer Biology and TherapeuticsMASSACHUSETTS GENERAL HOSPITAL1997–2028
- Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsyMASSACHUSETTS GENERAL HOSPITAL2021–2026
- High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cellsMASSACHUSETTS GENERAL HOSPITAL2021–2025
- Data Production, And Informatics And IntegrationNational Human Genome Research Institute2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
